Institut National de la Santé et de la Recherche Médicale, U837, Place de Verdun, Lille, France.
Gene Ther. 2010 Jul;17(7):880-91. doi: 10.1038/gt.2010.37. Epub 2010 Apr 15.
Human adenoviruses (HAdV) are widely used for in vitro and in vivo gene transfer. Viral hepatotropism, inflammatory responses and neutralization by pre-existing antibodies (NAbs) are obstacles for clinical applications of HAdV vectors. Although the multifactorial events leading to innate HAdV toxicity are far from being elucidated, there is a consensus that the majority of intravenously injected-HAdV vectors is sequestered by Kuppfer cells, probably independently of coagulation factors. In this study, we show that the adenoviral-associated humoral and innate cytokine immune responses are significantly reduced when HAdV-5 vector carrying human bovine chimeric fibers (HAdV-5-F2/BAdV-4) is intravenously injected into mice. Fiber pseudotyping modified its interaction with blood coagulation factors, as FIX and FX no longer mediate the infection of liver cells by HAdV-5-F2/BAdV-4. As a consequence, at early time points post-infection, several cytokines and chemokines (IFN-gamma, IL-6, IP-10, MCP-1, RANTES and MP1beta) were found to be present at lower levels in the plasma of mice that had been intravenously injected with HAdV-5-F2/BAdV-4 compared with mice injected with the parental vector HAdV-5. Moreover, genetic modification of the fiber allowed HAdV-5-F2/BAdV-4 to partially escape neutralization by NAbs.
人腺病毒(HAdV)广泛用于体外和体内基因转移。病毒嗜肝性、炎症反应和预先存在的抗体(NAbs)的中和作用是 HAdV 载体临床应用的障碍。尽管导致先天 HAdV 毒性的多因素事件远未阐明,但人们普遍认为,大多数静脉注射的 HAdV 载体被库普弗细胞隔离,可能与凝血因子无关。在这项研究中,我们表明,当携带人牛嵌合纤维的 HAdV-5 载体(HAdV-5-F2/BAdV-4)静脉注射到小鼠体内时,HAdV-5 载体相关的体液和先天细胞因子免疫反应显著降低。纤维假型改变了它与血液凝固因子的相互作用,因为 FIX 和 FX 不再介导 HAdV-5-F2/BAdV-4 感染肝细胞。因此,在感染后早期时间点,与注射亲本载体 HAdV-5 的小鼠相比,静脉注射 HAdV-5-F2/BAdV-4 的小鼠血浆中几种细胞因子和趋化因子(IFN-γ、IL-6、IP-10、MCP-1、RANTES 和 MP1β)的水平较低。此外,纤维的遗传修饰允许 HAdV-5-F2/BAdV-4 部分逃避 NAbs 的中和作用。